AA
BSX icon

AlphaCentric Advisors’s Boston Scientific BSX Stock Holding History

AlphaCentric Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.67M Buy
+18,667
New +$1.64M 1.66% 15
2024
Q2 		– Sell
-3,337
Closed -$229K – 222
2024
Q1 		$229K Sell
3,337
-316
-9% -$20.3K 0.14% 122
2023
Q4 		$211K Sell
3,653
-540
-13% -$28.8K 0.14% 107
2023
Q3 		$221K Sell
4,193
-166
-4% -$8.71K 0.13% 135
2023
Q2 		$236K Buy
+4,359
New +$228K 0.13% 132

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AlphaCentric Advisors's BSX Position: Q4 2024 in Review

AlphaCentric Advisors opened a new position in Boston Scientific (BSX) in Q4 2024: 18,667 shares worth $1.67M. The stake represents 1.66% of the portfolio and ranks #15 among its holdings. This is a return to the name: AlphaCentric Advisors previously reported a position in BSX as recently as Q1 2024.

AlphaCentric Advisors first reported a position in BSX in Q2 2023 and has held it in 5 quarters since. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • AlphaCentric Advisors held 18,667 shares of Boston Scientific worth $1.67M as of Q4 2024.
  • Boston Scientific was a new AlphaCentric Advisors position in Q4 2024.
  • Boston Scientific made up 1.66% of AlphaCentric Advisors's portfolio in Q4 2024, its #15 holding.
  • AlphaCentric Advisors first reported a position in Boston Scientific in Q2 2023 and has held it in 5 quarters since.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.